Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Exelixis Inc (EXEL)  
$22.03 0.10 (0.45%) as of 4:30 Tue 6/11


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 310,240,000
Market Cap: 6.83(B)
Last Volume: 1,350,945 Avg Vol: 2,431,686
52 Week Range: $18.78 - $24.13
Level I Sector: Industrials
Level II Sector: Diversified Services
Level III Sector: Research Services

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 17.5
Insider 6 Months    : 18.9
Insider 3/6 Months : 36.8
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Exelixis is an oncology-focused biotechnology company that engages in the discovery, development and commercialization of new medicines for cancers. Co.'s products include: CABOMETYX® (cabozantinib) tablets approved for renal cell carcinoma, and for previously treated hepatocellular carcinoma; and COMETRIQ® (cabozantinib) capsules approved for progressive, metastatic medullary thyroid cancer. The other products are: COTELLIC® (cobimetinib), an inhibitor of MEK approved as part of a combination regimen to treat forms of melanoma; and MINNEBRO® (esaxerenone), an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved for the treatment of hypertension in Japan.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 425,000 615,000 735,409 735,409
Total Buy Value $8,733,955 $12,666,689 $15,268,727 $15,268,727
Total People Bought 1 1 1 1
Total Buy Transactions 2 3 4 4
Total Shares Sold 88,818 210,838 601,659 1,021,249
Total Sell Value $1,938,121 $4,689,450 $12,908,109 $20,266,173
Total People Sold 5 7 9 12
Total Sell Transactions 6 9 17 28
End Date 2024-03-14 2023-12-12 2023-06-13 2022-06-13

   
Records found: 1438
  Page 28 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Willsey Lance Director   –       •      –    2019-02-20 4 OE $4.16 $115,350 D/D 26,250 444,523     -
   Cohen Charles Director   –       •      –    2019-02-19 4 S $21.48 $1,034,906 D/D (48,180) 0     -
   Cohen Charles Director   –       •      –    2019-02-15 4 S $22.19 $2,219,000 D/D (100,000) 48,180     -
   Feldbaum Carl B Director   –       •      –    2019-02-15 4 GD $0.00 $0 D/D 6,700 8,521     -
   Schwab Gisela Md Pres, Prod Dev & Med Aff & CMO   •       –      –    2019-02-15 4 S $22.20 $510,600 D/D (23,000) 316,513     -
   Schwab Gisela Md Pres, Prod Dev & Med Aff & CMO   •       –      –    2019-02-15 4 OE $5.56 $127,880 D/D 23,000 339,513     -
   Cohen Charles Director   –       •      –    2019-02-14 4 S $22.41 $2,241,000 D/D (100,000) 148,180     -
   Morrissey Michael M President and CEO   •       •      –    2019-02-14 4 AS $22.39 $895,654 D/D (40,000) 90,000     -
   Morrissey Michael M President and CEO   •       •      –    2019-02-14 4 OE $5.56 $222,400 D/D 40,000 130,000     -
   Feldbaum Carl B Director   –       •      –    2019-02-14 4 S $22.03 $1,112,515 D/D (50,500) 15,221     -
   Feldbaum Carl B Director   –       •      –    2019-02-14 4 OE $4.57 $251,275 D/D 50,500 65,721     -
   Schwab Gisela Md Pres, Prod Dev & Med Aff & CMO   •       –      –    2019-02-14 4 S $21.66 $2,166,000 D/D (100,000) 316,513     -
   Schwab Gisela Md Pres, Prod Dev & Med Aff & CMO   •       –      –    2019-02-14 4 OE $5.56 $556,000 D/D 100,000 416,513     -
   Haley Patrick J. Sr. Vice President, Commercial   •       –      –    2019-02-11 4 AS $21.30 $21,300 D/D (1,000) 95,011     -
   Scangos George A Director   –       •      –    2019-02-01 4 AS $23.53 $941,200 D/D (40,000) 1,363,031     -
   Morrissey Michael M President and CEO   •       •      –    2019-01-30 4 AS $23.12 $924,800 D/D (40,000) 90,000     -
   Morrissey Michael M President and CEO   •       •      –    2019-01-30 4 OE $5.56 $222,400 D/D 40,000 130,000     -
   Morrissey Michael M President and CEO   •       •      –    2019-01-16 4 AS $23.28 $931,456 D/D (40,000) 90,000     -
   Morrissey Michael M President and CEO   •       •      –    2019-01-16 4 OE $5.56 $222,400 D/D 40,000 130,000     -
   Haley Patrick J. Sr. Vice President, Commercial   •       –      –    2019-01-10 4 AS $23.54 $71,540 D/D (3,000) 96,011     -
   Haley Patrick J. Sr. Vice President, Commercial   •       –      –    2019-01-10 4 OE $1.76 $3,520 D/D 2,000 99,011     -
   Haley Patrick J. Sr. Vice President, Commercial   •       –      –    2019-01-09 4 AS $23.50 $36,660 D/D (1,560) 97,011     -
   Haley Patrick J. Sr. Vice President, Commercial   •       –      –    2019-01-09 4 OE $5.82 $9,079 D/D 1,560 98,571     -
   Garber Alan M Director   –       •      –    2019-01-08 4 AS $23.00 $258,750 D/D (11,250) 61,329     -
   Garber Alan M Director   –       •      –    2019-01-08 4 OE $4.16 $46,800 D/D 11,250 72,579     -
  1438 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 28 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us